CN109438345A - A kind of synthetic method of two deuterated primaquine - Google Patents

A kind of synthetic method of two deuterated primaquine Download PDF

Info

Publication number
CN109438345A
CN109438345A CN201811350876.3A CN201811350876A CN109438345A CN 109438345 A CN109438345 A CN 109438345A CN 201811350876 A CN201811350876 A CN 201811350876A CN 109438345 A CN109438345 A CN 109438345A
Authority
CN
China
Prior art keywords
primaquine
deuterated
synthetic method
reaction
heavy water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811350876.3A
Other languages
Chinese (zh)
Inventor
徐红岩
殷海峰
李响
杨新贺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kang (shanghai) New Medicine Research & Development Co Ltd
Original Assignee
Kang (shanghai) New Medicine Research & Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kang (shanghai) New Medicine Research & Development Co Ltd filed Critical Kang (shanghai) New Medicine Research & Development Co Ltd
Priority to CN201811350876.3A priority Critical patent/CN109438345A/en
Publication of CN109438345A publication Critical patent/CN109438345A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Abstract

The technical problems such as the present invention relates to a kind of synthetic method of two deuterated primaquine, it is long mainly to solve route existing for existing synthetic method, at high cost, cumbersome, and yield is low.The present invention is achieved through the following technical solutions: a kind of synthetic method of two deuterated primaquine, it is characterized in that, using primaquine phosphate as starting material, heavy water is solvent, and the acid of catalytic amount, heating reaction is added, it pours into buck after reaction, extraction, it is dry, two deuterated primaquine are obtained after concentration.The present invention has route simple, and raw material is easy to get, high income, at low cost, convenient post-treatment and the advantages that obtain the purity and high D abundance of product.

Description

A kind of synthetic method of two deuterated primaquine
Technical field
The present invention relates to a kind of synthetic methods of two deuterated primaquine, belong to deuterated drug production field.
Background technique
In many cases, carbon deuterium key can be slowed down with deuterium for a small number of hydrogen atoms in drug to be enzymatically decomposed, can stopped in vivo For more time, while the formation of toxic metabolic products is reduced.Therefore, in general, compared to not deuterated drug, deuterated drug has Toxic side effect is reduced, increases medicine stability, heightens the effect of a treatment, extends the effects of drug biological half-life.In April, 2017, ladder watt The AUSTEDO (deutetrabenazine) of company becomes first deuterated drug ratified by FDA.Deuterated drug Research and development cause the broad interest of domestic and international medicine enterprise.
(WO 2011091035) according to the literature, two deuterated primaquine are using p-nitrophenol as starting material, by 8 Step reaction synthesis key intermediate quinoline ring, and pass through number step and react final synthesising target compound, which has route long, It is at high cost, cumbersome, the disadvantages such as yield is low.
Summary of the invention
The purpose of the present invention is to provide a kind of synthetic methods of deuterated primaquine.Existing synthetic method is mainly solved to exist Route it is long, at high cost, cumbersome, the technical problems such as yield is low.
The present invention is achieved through the following technical solutions: a kind of synthetic method of two deuterated primaquine, which is characterized in that Using primaquine phosphate as starting material, heavy water is solvent, and the acid of catalytic amount is added, and buck is poured into heating reaction after reaction In, it extracts, it is dry, two deuterated primaquine are obtained after concentration.
As optimal technical scheme, in above-mentioned reaction, heavy water dosage is 5-15 times of primaquine phosphate weight, preferably 10 Times.
In above-mentioned reaction, reaction temperature is 55-110 DEG C, preferably 90-100 DEG C.
In above-mentioned reaction, reaction time 4-24 hour, preferably 8-10 hour.
In above-mentioned reaction, acid used is sulfuric acid.
In above-mentioned reaction, it is molten that buck used is selected from saturated sodium carbonate solution, unsaturated carbonate potassium solution or saturated sodium bicarbonate One of liquid, preferably saturated sodium carbonate solution.
Concrete technology route of the present invention is as follows:
Beneficial effects of the present invention: compared with the existing technology, the present invention has route simple to technical solution of the present invention, and raw material is easy , yield is up to 95%, at low cost, convenient post-treatment and the advantages that obtain the purity and high D abundance of product.
Specific embodiment
Present pre-ferred embodiments are given below, in order to explain the technical scheme of the invention in detail.
Embodiment 1
Primaquine phosphate (200 mg) is added into there-necked flask, heavy water (2 mL) is added the concentrated sulfuric acid (0.1mL), is heated to 95 DEG C, 8h is reacted, is poured into saturated sodium carbonate solution after reaction (20 mL), ethyl acetate extracts (20 mL x 2), anhydrous slufuric acid Sodium is dry, and two deuterated primaquine (109 mg, 95% yield) are obtained after concentration.1H NMR (300MHz, DMSO-d6):8.21 (dd, J = 4.5Hz,1.2Hz, 1H), 8.01 (dd, J = 8.4Hz,1.2Hz, 1H), 7.31 (dd, J = 8.4Hz,4.5Hz, 1H),3.44(s, 3H), 3.19(m, 1H), 2.70 (m, 2H), 1.40(m, 4H), 0.91 (d, J= 6.0 Hz, 3H);13C NMR (75MHz, DMSO-d6): 159.76, 144.28, 138.92, 138.07, 131.04, 124.54, 121.33, 55.60, 48.65, 39.33, 31.59, 23.26, 18.20。
Embodiment 2
Primaquine phosphate (200 mg) is added into there-necked flask, heavy water (2 mL) is added the concentrated sulfuric acid (0.1mL), is heated to 55 DEG C, Reaction for 24 hours, is poured into saturated sodium carbonate solution (20 mL) after reaction, and ethyl acetate extracts (20 mL x 2), anhydrous sulphur Sour sodium is dry, and two deuterated primaquine (103 mg, 90% yield) are obtained after concentration.
Embodiment 3
Primaquine phosphate (200 mg) is added into there-necked flask, heavy water (2 mL) is added the concentrated sulfuric acid (0.1mL), is heated to 110 DEG C, 4h is reacted, is poured into saturated sodium carbonate solution after reaction (20 mL), ethyl acetate extracts (20 mL x 2), anhydrous Sodium sulphate is dry, and two deuterated primaquine (102 mg, 89% yield) are obtained after concentration.

Claims (10)

1. a kind of synthetic method of two deuterated primaquine, which is characterized in that using primaquine phosphate as starting material, heavy water is molten The acid of catalytic amount is added in agent, and heating reaction is poured into buck after reaction, extracted, dry, and two deuterated primary are obtained after concentration Ammonia quinoline.
2. a kind of synthetic method of two deuterated primaquine according to claim 1, which is characterized in that heavy water dosage is phosphoric acid 5-15 times of primaquine weight.
3. a kind of synthetic method of two deuterated primaquine according to claim 2, which is characterized in that heavy water dosage is 10 Times.
4. a kind of synthetic method of two deuterated primaquine according to claim 1, which is characterized in that reaction temperature 55- 110℃。
5. a kind of synthetic method of two deuterated primaquine according to claim 4, which is characterized in that reaction temperature 90- 100℃。
6. a kind of synthetic method of two deuterated primaquine according to claim 1, which is characterized in that the reaction time, 4-24 was small When.
7. a kind of synthetic method of two deuterated primaquine according to claim 6, which is characterized in that the reaction time, 8-10 was small When.
8. a kind of synthetic method of two deuterated primaquine according to claim 1, which is characterized in that acid used is sulphur Acid.
9. a kind of synthetic method of two deuterated primaquine according to claim 1, which is characterized in that buck used is selected from full One of with sodium carbonate liquor, unsaturated carbonate potassium solution or saturated sodium bicarbonate solution.
10. a kind of synthetic method of two deuterated primaquine according to claim 9, which is characterized in that buck used is full And sodium carbonate liquor.
CN201811350876.3A 2018-11-14 2018-11-14 A kind of synthetic method of two deuterated primaquine Pending CN109438345A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811350876.3A CN109438345A (en) 2018-11-14 2018-11-14 A kind of synthetic method of two deuterated primaquine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811350876.3A CN109438345A (en) 2018-11-14 2018-11-14 A kind of synthetic method of two deuterated primaquine

Publications (1)

Publication Number Publication Date
CN109438345A true CN109438345A (en) 2019-03-08

Family

ID=65553227

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811350876.3A Pending CN109438345A (en) 2018-11-14 2018-11-14 A kind of synthetic method of two deuterated primaquine

Country Status (1)

Country Link
CN (1) CN109438345A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112724087A (en) * 2021-02-04 2021-04-30 康化(上海)新药研发有限公司 Synthesis method of dideuterotrimethoprim

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091035A1 (en) * 2010-01-19 2011-07-28 Concert Pharmaceuticals, Inc. Aminoquinoline derivatives
CN102392267A (en) * 2011-09-19 2012-03-28 华东理工大学 8, 9-tetradeuterium cetane and preparation method thereof
CN106892790A (en) * 2017-03-16 2017-06-27 南京工业大学 The method that a kind of utilization microchannel reaction unit prepares deuterated amino benzenes compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091035A1 (en) * 2010-01-19 2011-07-28 Concert Pharmaceuticals, Inc. Aminoquinoline derivatives
CN102392267A (en) * 2011-09-19 2012-03-28 华东理工大学 8, 9-tetradeuterium cetane and preparation method thereof
CN106892790A (en) * 2017-03-16 2017-06-27 南京工业大学 The method that a kind of utilization microchannel reaction unit prepares deuterated amino benzenes compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDREW MARTINS,等: "A Simple, Cost-Effective Method for the Regioselective Deuteration of Anilines", 《ORGANIC LETTERS》 *
JUN XU,等: "Copper(II)-catalyzed C5 and C7 halogenation of quinolines using sodium halides under mild conditions", 《ORG. BIOMOL. CHEM.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112724087A (en) * 2021-02-04 2021-04-30 康化(上海)新药研发有限公司 Synthesis method of dideuterotrimethoprim

Similar Documents

Publication Publication Date Title
CN102584795B (en) Preparing method of crizotinib
CN100503601C (en) Process of preparing troipisetron
CN106631960A (en) Method for synthesizing oxiracetam
CN106699570A (en) Synthesis method for (2-chloro-5-iodophenyl)(4-fluorophenyl)ketone
CN101870653B (en) Synthesis method of 2 - methyl -3 - fluoride - 6 -nitrobenzoic acid
CN109438345A (en) A kind of synthetic method of two deuterated primaquine
CN104130188A (en) Preparation method of 8-chloro-1-methyl-2,3,4,5- tetrahydro -1H-3-benzoazatropylidene
CN105541801B (en) The synthetic method of EZH2 methyltransferase inhibitors GSK126
CN102321086B (en) Synthesizing method of adenine
CN104370935B (en) A kind of preparation method of bisulfate clopidogrel
CN105085242A (en) Synthetic method of high-quality acetonedicarboxylic acid and acetonedicarboxylate
CN105152947A (en) Preparation method of 2-amino-3,5-dibromobenzaldehyde
CN114380732B (en) Preparation method of fluoroindole carboxylic acid compound
CN105175355B (en) A kind of preparation method of 2- cyano-phenothiazines
CN101580473B (en) Method for preparing N-methyl paranitroaniline
CN103183599A (en) Method for preparing 2-valproic acid
CN103923003A (en) Preparation method of 4-bromomethylquinoline-2(H)-ketone
CN110128298B (en) Synthetic method of Sacubitril intermediate
CN104418810A (en) New synthetic route of levosimendan
CN103664960B (en) Pu Na is for the preparation method of Buddhist nun
CN105130806A (en) Method of reducing impurities in synthesis process of emtricitabine intermediate MGH
WO2015012271A1 (en) Method for producing heterocyclic compound
CN104003936A (en) Refining and purification method of dextromethorphan hydrobromide
CN102627595A (en) Method for preparation of glycopyrronium bromide
CN112939893A (en) Synthesis method of 4- (4-aminophenyl) -3-morpholinone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190308